Brepocitinib in patients with #dermatomyositis was associated with improvements in cutaneous disease activity, #pruritus, and skin-related quality of life through 52 weeks.
@dermatologyadvisor.bsky.social
@dermatologyadvisor.bsky.socialBrepocitinib in patients with #dermatomyositis was associated with improvements in cutaneous disease activity, #pruritus, and skin-related quality of life through 52 weeks.
@4040rec.bsky.social@dermatologyadvisor.bsky.socialAt 2 years of treatment, 96.6% of those with moderate to severe #AtopicDermatitis reported meaningful benefit; 74.9% reported improvement in #pruritus relief — the highest rated priority.
@karl-theodor.mastodon.social.ap.brid.gy📗 👓 #Cannabisstudien06 #Vegetativ #Sonstige 105
#Schlafstörungen 42
#OpioidReduktion 32
#GeriatrischePatienten 13
#Pruritus 4
#Schlafapnoe 4
#Glaukom 3
#LongCOVID 2
#AtopischeDermatitis 2
#Psoriasis 2
#Fatigue 1
Ein kuratierter Bestand geprüfter 🌱 #Cannabinoid […]